List of SBIR/STTR awards granted to Cassava Sciences
Cassava SciencesA SBIR Phase II contract was awarded to Cassava Sciences in May, 2020 for $2,499,896.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Cassava Sciences in January, 2019 for $1,109,748.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Cassava Sciences in December, 2018 for $2,896,561.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Cassava Sciences in September, 2018 for $635,085.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Cassava Sciences in September, 2017 for $295,343.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Cassava Sciences in January, 2016 for $1,500,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Cassava Sciences in June, 2017 for $225,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Cassava Sciences in January, 2016 for $1,725,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Cassava Sciences for $100,000.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Cassava Sciences for $100,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Cassava Sciences for $100,000.0 USD from the U.S. Department of Health & Human Services.
